regeneron glp-1 gip treatment muscle loss side effects Emerging Role of Myostatin Inhibitors in the Management of Glucagon-Like Peptide-1-Associated Sarcopenia and Metabolic Disorders The potential of glucagon-like peptide-1

Metabolic Benefits Beyond Weight Loss Those metabolic effects are not limited to weight loss

Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance

doi: 10.1517/17460441.2015.1044966 3 Perez-CamposEMayoralL-CAndradeGMayoralE-CHuertaTCansecoSet al

Last reviewed: July 3, 2026 Last updated: July 3, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Helps with appetite control : Lower doses can assist in curbing cravings and support more careful eating habits

The warning exists because, during early laboratory trials, GLP-1 medications were found to cause a rare type of thyroid cancer (Medullary Thyroid Cancer) in rats